422 related articles for article (PubMed ID: 11015995)
1. [Hepatic arterial infusion chemotherapy using totally implantable port system].
Takayasu Y; Yamamoto S; Ikeda J
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Motohara T; Ozawa Z; Morita S
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
[TBL] [Abstract][Full Text] [Related]
3. [Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Kamiyama T; Une Y; Nakajima Y; Matsuoka S; Nagabuchi E; Gotoda A; Saito M; Uchino J
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1851-5. PubMed ID: 1652225
[TBL] [Abstract][Full Text] [Related]
4. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
[TBL] [Abstract][Full Text] [Related]
5. [Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Higashi S; Kato C; Sakumoto H; Sumiyoshi K; Takahahsi T; Matsumoto K; Kane T; Sakoda M; Takahashi M; Hosono Y; Asano M; Yamamoto A
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1764-7. PubMed ID: 10560390
[TBL] [Abstract][Full Text] [Related]
6. [Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma].
Nakazaki H; Kuramoto S; Watanabe M; Maeda T; Hanawa S; Hasebe Y; Suzuki Y; Yanagita K; Yoshio T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1501-3. PubMed ID: 1326917
[TBL] [Abstract][Full Text] [Related]
7. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
[TBL] [Abstract][Full Text] [Related]
8. [Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
Iwamiya T; Sawada S; Morioka N; Tanigawa N; Kobayashi M; Nakamura K; Okuda Y; Hashimoto M; Ohta Y; Kawasaki H
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2213-7. PubMed ID: 1332626
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
[TBL] [Abstract][Full Text] [Related]
10. [Study of continuous arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with hepatocellular carcinoma].
Takao T; Nisida M; Maeda Y; Mori N; Tamesa T; Tangoku A; Oka M
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1836-40. PubMed ID: 10560407
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic arterial infusion chemotherapy for hepatocellular carcinoma by EEP regimen].
Takayasu Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():624-8. PubMed ID: 11762024
[No Abstract] [Full Text] [Related]
13. Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma.
Murata K; Shiraki K; Kawakita T; Yamamoto N; Okano H; Nakamura M; Sakai T; Deguchi M; Ohmori S; Nakano T
Anticancer Res; 2003; 23(2C):1719-22. PubMed ID: 12820447
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein.
Itamoto T; Nakahara H; Tashiro H; Haruta N; Asahara T; Naito A; Ito K
J Surg Oncol; 2002 Jul; 80(3):143-8. PubMed ID: 12115797
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma treated by continuous hepatic arterial infusion of etoposide, CDDP and 5-FU].
Tarusawa K; Yodono H; Sasaki T; Ikami I; Fujii N; Akimura R; Nakamura Y; Kanehira J; Midorikawa H; Kimura T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):53-8. PubMed ID: 2153370
[TBL] [Abstract][Full Text] [Related]
16. [The chemotherapy for hepatocellular carcinoma].
Nagano H; Sakon M; Monden M
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1895-900. PubMed ID: 14650956
[TBL] [Abstract][Full Text] [Related]
17. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
Takeda Y; Hasuike Y; Tsujinaka T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1712-7. PubMed ID: 11708016
[TBL] [Abstract][Full Text] [Related]
18. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
[TBL] [Abstract][Full Text] [Related]
19. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
Tarusawa K; Yodono H; Ikami I; Sasaki T; Kanehira J; Takahashi S; Shibutani K; Noda H; Shinohara A; Takekawa D
Gan To Kagaku Ryoho; 1992 Mar; 19(3):383-6. PubMed ID: 1311915
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of arterial infusion chemotherapy for advanced gallbladder cancer using implantable port].
Hata Y; Morita S; Hisa N; Fujiwara Y; Higaki T; Kamiike O; Yoshida D; Yoshida S
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2639-43. PubMed ID: 7979425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
